A recent advisory by the FDA urging breast imaging facilities to ensure compatibility between full-field digital mammography systems and PACS exposed an ongoing problem: Interoperability issues persist as some vendors fail to comply with healthcare digital imaging standards.
A recent advisory by the FDA urging breast imaging facilities to ensure compatibility between full-field digital mammography systems and PACS exposed an ongoing problem: Interoperability issues persist as some vendors fail to comply with healthcare digital imaging standards.
The FDA learned that image quality from a number of FFDM units was being compromised when displayed on some third-party PACS. According to the agency:
These issues could lead radiologists to overlook or misplace suspicious lesions, a problem that escalates when images end up at facilities unfamiliar with the configuration of equipment originally used to perform the mammogram. The FDA thus recommended July 29 that all facilities check to ensure that image-identifying information is correctly displayed on both soft- and hard-copy FFDM images.
This issue highlights why it is critical for purchasers of digital mammography, mammography computer-aided detection, and PACS and workstation equipment to contractually bind their vendors to strict support of all relevant portions of the DICOM standard as well as the technical frameworks of the Integrating the Healthcare Enterprise initiative, specifically the Mammography Image Integration Profile, said Dr. David S. Channin, chief of imaging informatics at Northwestern University's Feinberg School of Medicine in Chicago."These standardization efforts are specifically focused on reducing these kinds of interoperability issues across systems and vendors," Channin told
Diagnostic
Imaging.Each year, the IHE holds connectathons in Asia, Europe, and North America. The connectathon is a large-scale healthcare IT industry interoperability testing event where vendors of multiple systems and platforms check their connectivity, exchange information, and perform thousands of digital transactions. The IHE recently published the results from the IHE-Europe and IHE-North America connectathons. Of 32 PACS vendors, only 13 fulfilled IHE's image display
mammography integration profile
.The IHE Radiology Mammography subcommittee is always developing new technical frameworks that affect digital mammography. Therefore, customers must insist that their vendors participate in the IHE process and deliver support for the new IHE frameworks within a short time after their finalization, Channin said While participation in IHE and compliance with these frameworks cannot guarantee that issues like those identified by the FDA will not arise, they reduce the likelihood of such occurrences, he said."The FDA, for its part, should consider mandating such compliance as a way of accelerating market driven forces for adoption," Channin said.For more information from the Diagnostic Imaging archives:
Imaging informatics offers key to reshaping radiology's future
Japanese hospital reports favorable experience with CAD-PACS integration
Innovators team with vendors to broaden access to new tools
Digital mammography produces large data loads
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
What a New Review Reveals About Mammography-Based AI and Breast Cancer Risk Assessment
November 9th 2023Mammography-based artificial intelligence (AI) models demonstrated an 11 percent higher median AUC for predicting breast cancer than traditional clinical risk factors, according to a new systematic review of 16 retrospective studies.
Mammography News: FDA Clears AI Software for Breast Arterial Calcification Detection
October 17th 2023Utilized in conjunction with screening digital mammography or digital breast tomosynthesis (DBT), the artificial intelligence (AI)-powered software cmAngio may help detect and localize breast arterial calcification (BAC), an incidental finding that has been linked to an elevated risk for heart disease and stroke.